Lets hope that 2020 brings some relief for this sector that has been fodder for the shorts and under some controversial circumstances as analysts seem to placer downgrades at key levels on any signs of recovery.
Average analysts price target $11.00
Curaleaf Holdings announced that its has received commitments from a syndicate of lenders for the purpose of structuring a new USD $275 million financing.
The financing will be set up as a Senior Secured Term Loan Facility and carry with it a 13% per annum interest rate. The loan facility would mature 48 months from closing with interest payable quarterly in arrears. Since the loan facility does not include an equity component, it will not dilute the existing positions of Curaleaf shareholders.
Company profile
Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.
Average analysts price target $11.00
Curaleaf Holdings announced that its has received commitments from a syndicate of lenders for the purpose of structuring a new USD $275 million financing.
The financing will be set up as a Senior Secured Term Loan Facility and carry with it a 13% per annum interest rate. The loan facility would mature 48 months from closing with interest payable quarterly in arrears. Since the loan facility does not include an equity component, it will not dilute the existing positions of Curaleaf shareholders.
Company profile
Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.